Trial Identifier: | D1699C00017 |
Sponsor: | AstraZeneca |
Start Date: | May 2021 |
Primary Completion Date: | August 2024 |
Study Completion Date: | August 2024 |
Condition: | Congestive Heart Failure |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan | Fukushima, Japan |
Japan | Kochi, Japan |
Japan | Toyama, Japan |
Japan | Yamagata, Japan |